FDA begins process to remove breast cancer indication from Avastin label
Drug not shown to be safe and effective in breast cancer patients Erica Jefferson, December 2010 FDA Information The U.S. Food and Drug Administration announced today that the agency is recommending removing the breast cancer indication from the label for Avastin (bevacizumab) because the drug has not been shown to be safe and effective for [...]